# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 99

Extent: E+W+S+N.I.

For regulation 132 (omission of Part 8), substitute—
“Amendment of regulation 156 (article 126a authorisations)
132 In regulation 156—
(a) in paragraph (1)—
(i) after “126a authorisation for” insert “ sale or supply of ”;
(ii) after “medicinal product” insert “ in Northern Ireland only, ”;
(b) in paragraph (2), after “is in force” insert “ in Northern Ireland ”;
(c) in paragraph (3), after “traditional herbal registration” insert “ to be in force in Northern Ireland ”;
(d) in paragraph (4) for “the United Kingdom” substitute “ Northern Ireland ”; and
(e) in paragraph (5) for “another member State” substitute “ an EU member State ”.
Amendment of regulation 157 (requests from other member States)
132A In regulation 157(1)—
(a) in the heading for “other member States” substitute “ EU member States ”; and
(b) in paragraph (1)—
(i) after “where the licensing authority” insert “ , in relation to a UKMA(NI), ”; and
(ii) for “another member State” substitute “ a member State ”.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/99 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-99
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.